About Us Our BioBank Platform Technology Our Drug Programmes News Contact us Financials INVESTORS NEWS The Company’s year-end is 31 December. We report our financial results on a half yearly basis. Copies of the Report and accounts can be found here. Report and accounts Interim statements 25th May 2021 2020 Annual Report 3rd June 2020 2019 Annual Report 18th April 2019 2018 Annual Report 17th May 2018 2017 Annual Report 5th June 2017 2016 Annual Report 17th May 2016 2015 Annual Report 23rd April 2015 2014 Annual Report 1st January 2013 2013 Annual Report 1st January 2012 2012 Annual Report 31st December 2011 6 Months ended 31st December 2011 Report 1st January 2011 2011 Annual Report 1st January 2010 2010 Annual Report 1st January 2009 2009 Annual Report 1st January 2008 2008 Annual Report 1st January 2007 2007 Annual Report 1st January 2006 2006 Annual Report 1st January 2005 2005 Annual Report 30th September 2021 Interim results for the six months ended 30 June 2021 29th September 2020 Interim results for the six months ended 30 June 2020 30th September 2019 Interim results for the six months ended 30 June 2019 25th September 2018 2018 Interim Statement 27th September 2017 2017 Interim Statement 22nd September 2016 2016 Interim Statement 16th September 2015 2015 Interim Statement 25th September 2014 2014 Interim Statement 1st January 2013 2013 Interim Statement 1st January 2012 2012 Interim Statement 1st January 2011 2011 Interim Statement 1st January 2010 2010 Interim Statement 1st January 2009 2009 Interim Statement 1st January 2008 2008 Interim Statement 1st January 2007 2007 Interim Statement 1st January 2006 2006 Interim Statement 1st January 2005 2005 Interim Statement 1st January 2004 2004 Interim Statement Synairgen plc Registered in England and Wales No. 5233429 Registered office Mailpoint 810, Level F, South Block, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK